{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:41:11Z","timestamp":1790912471445,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.09.030","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T06:08:32Z","timestamp":1443247712000},"page":"5920-5926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":127,"title":["Advax\u2122, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8911-2663","authenticated-orcid":false,"given":"Nikolai","family":"Petrovsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1580-5245","authenticated-orcid":false,"given":"Peter D.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.09.030_bib0330","first-page":"67","article-title":"The chemistry and sources of fructose and their effect on functionality and health implications","volume":"3","author":"Barclay","year":"2012","journal-title":"J Excipients Food Chem"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0335","series-title":"La vie c\u2019est bon comme tout","first-page":"5","author":"Leroux","year":"1996"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0340","series-title":"Inulin-type fructans functional food ingredients","author":"Robertfroid","year":"2004"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0345","series-title":"Inulin polysaccharides and polyamides in the food industry properties, production and patents","first-page":"281","author":"Franck","year":"2005"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0350","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/S0007114599001087","article-title":"The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women","volume":"82","author":"Jackson","year":"1999","journal-title":"Br J Nutr"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0355","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/jn\/132.5.967","article-title":"Dietary fructans, but not cellulose, decrease triglyceride accumulation in the liver of obese Zucker fa\/fa rats","volume":"132","author":"Daubioul","year":"2002","journal-title":"J Nutr"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0360","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1017\/BJN20061913","article-title":"Inulin attenuates atherosclerosis in apolipoprotein E-deficient mice","volume":"96","author":"Rault-Nania","year":"2006","journal-title":"Br J Nutr"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0365","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mrfmmm.2004.02.017","article-title":"New approaches to the role of diet in the prevention of cancers of the alimentary tract","volume":"551","author":"Johnson","year":"2004","journal-title":"Mutat Res"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0370","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/carcin\/23.11.1953","article-title":"Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats","volume":"23","author":"Femia","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0375","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrendo.2009.273","article-title":"Immunomodulation with microbial vaccines to prevent type 1 diabetes mellitus","volume":"6","author":"Petrovsky","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0380","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1172\/JCI100690","article-title":"The excretion of inulin, xylose and urea by normal and phlorizinized man","volume":"14","author":"Shannon","year":"1935","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0385","unstructured":"British Pharmaceutical codex 1979."},{"key":"10.1016\/j.vaccine.2015.09.030_bib0390","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1084\/jem.134.3.90","article-title":"The c3-activator system: an alternate pathway of complement activation","volume":"134","author":"Gotze","year":"1971","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0395","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1040-8428(85)80012-3","article-title":"Protein A and staphylococcal products in neoplastic disease","volume":"4","author":"Terman","year":"1985","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0400","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-4612-5068-5_4","article-title":"Complement and cancer: activation of the alternative pathway as a theoretical base for immunotherapy","volume":"1","author":"Cooper","year":"1985","journal-title":"Adv Immun Cancer Ther"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0405","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1042\/bj0950041","article-title":"The physical properties of inulin solutions","volume":"95","author":"Phelps","year":"1965","journal-title":"Biochem J"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0410","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0264-410X(91)90063-C","article-title":"Algammulin, a new vaccine adjuvant comprising gamma inulin particles containing alum: preparation and in vitro properties","volume":"9","author":"Cooper","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0415","series-title":"Activators and inhibitors of complement","first-page":"69","author":"Cooper","year":"1993"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0420","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0161-5890(86)90076-3","article-title":"The anti-melanoma activity of inulin in mice","volume":"23","author":"Cooper","year":"1986","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0425","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.bjc.6603508","article-title":"Potentiation of photodynamic therapy of cancer by complement: the effect of gamma-inulin","volume":"96","author":"Korbelik","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0430","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1126\/science.271.5247.348","article-title":"C3d of complement as a molecular adjuvant: bridging innate and acquired immunity","volume":"271","author":"Dempsey","year":"1996","journal-title":"Science"},{"issue":"Pt 5\u20136","key":"10.1016\/j.vaccine.2015.09.030_bib0435","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/icb.1988.45","article-title":"The adjuvanticity of gamma inulin","volume":"66","author":"Cooper","year":"1988","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0440","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1440-1711.2004.01290.x","article-title":"Inulin-derived adjuvants efficiently promote both Th1 and Th2 immune responses","volume":"82","author":"Silva","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0445","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1189\/jlb.69.1.69","article-title":"Adjuvant effect of gamma-inulin is mediated by C3 fragments deposited on antigen-presenting cells","volume":"69","author":"Kerekes","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0450","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12519-014-0477-x","article-title":"Aluminum exposure and toxicity in neonates: a practical guide to halt aluminum overload in the prenatal and perinatal periods","volume":"10","author":"Fanni","year":"2014","journal-title":"World J Pediatr"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0455","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0889-8561(03)00095-X","article-title":"Aluminum inclusion macrophagic myofasciitis: a recently identified condition","volume":"23","author":"Gherardi","year":"2003","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0460","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/DER.0b013e31825228cf","article-title":"Hypersensitivity reactions to vaccine constituents: a case series and review of the literature","volume":"23","author":"Leventhal","year":"2012","journal-title":"Dermatitis"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0465","doi-asserted-by":"crossref","first-page":"e35421","DOI":"10.1371\/journal.pone.0035421","article-title":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus","volume":"7","author":"Tseng","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0470","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/glycob\/cwq201","article-title":"Delta inulin: a novel, immunologically active, stable packing structure comprising beta-d-[2\u21921] poly(fructo-furanosyl) alpha-d-glucose polymers","volume":"21","author":"Cooper","year":"2011","journal-title":"Glycobiology"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0475","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/glycob\/cwt053","article-title":"The polysaccharide inulin is characterized by an extensive series of periodic isoforms with varying biological actions","volume":"23","author":"Cooper","year":"2013","journal-title":"Glycobiology"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0480","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0141-8130(95)01075-0","article-title":"Single crystals of inulin","volume":"18","author":"Andre","year":"1996","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0485","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.carbpol.2013.12.066","article-title":"Inulin isoforms differ by repeated additions of one crystal unit cell","volume":"103","author":"Cooper","year":"2014","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0490","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.carbpol.2014.10.022","article-title":"Inulin crystal initiation via a glucose\u2013fructose cross-link of adjacent polymer chains: atomic force microscopy and static molecular modelling","volume":"117","author":"Cooper","year":"2015","journal-title":"Carbohydr Polym"},{"issue":"Suppl. 8","key":"10.1016\/j.vaccine.2015.09.030_bib0495","doi-asserted-by":"crossref","first-page":"I15","DOI":"10.1016\/j.vaccine.2008.11.023","article-title":"Discrimination between host and pathogens by the complement system","volume":"26","author":"Pangburn","year":"2008","journal-title":"Vaccine"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2015.09.030_bib0500","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1042\/bj3020429","article-title":"Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation","volume":"302","author":"Sahu","year":"1994","journal-title":"Biochem J"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0505","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/intimm\/1.5.551","article-title":"SP-40,40 is an inhibitor of C5b-6-initiated haemolysis","volume":"1","author":"Murphy","year":"1989","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0510","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.vaccine.2013.11.105","article-title":"Gamma ray sterilization of delta inulin adjuvant particles (Advax\u2122) makes minor, partly reversible structural changes without affecting adjuvant activity","volume":"32","author":"Cooper","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0515","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.vaccine.2012.12.077","article-title":"A novel hepatitis B vaccine containing Advax\u2122, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing","volume":"31","author":"Saade","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0520","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1574-695X.2001.tb00535.x","article-title":"CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice","volume":"32","author":"Weeratna","year":"2001","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0525","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants","volume":"453","author":"Eisenbarth","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0530","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1016\/j.vaccine.2012.06.021","article-title":"Advax\u2122, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses","volume":"30","author":"Honda-Okubo","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0535","first-page":"118","article-title":"Enhanced pulmonary immunization with aerosolized inactivated influenza vaccine containing delta inulin adjuvant","volume":"66C","author":"Murugappan","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0540","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1016\/j.vaccine.2014.06.057","article-title":"A single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax) overcomes pregnancy-associated immune suppression and enhances passive neonatal protection","volume":"32","author":"Honda-Okubo","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0545","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1016\/j.vaccine.2011.06.078","article-title":"Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets","volume":"29","author":"Layton","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0550","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1128\/CVI.00019-14","article-title":"Advax\u2122-adjuvanted recombinant protective antigen provides protection against inhalational anthrax that is further enhanced by addition of murabutide adjuvant","volume":"21","author":"Feinen","year":"2014","journal-title":"Clin Vaccin Immunol"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0555","article-title":"Japanese encephalitis vaccines: WHO position paper, February 2015 \u2013 recommendations","author":"WHO","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0560","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1099\/vir.0.019190-0","article-title":"An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax\u2122, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses","volume":"91","author":"Lobigs","year":"2010","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0565","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1128\/JVI.03144-12","article-title":"JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8+ T cells and pre-exposure neutralizing antibody","volume":"87","author":"Larena","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0570","doi-asserted-by":"crossref","first-page":"10324","DOI":"10.1128\/JVI.00480-13","article-title":"An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibody","volume":"87","author":"Petrovsky","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0575","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13567-014-0130-7","article-title":"Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals","volume":"45","author":"Bielefeldt-Ohmann","year":"2014","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0580","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1128\/JVI.02980-14","article-title":"Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology","volume":"89","author":"Honda-Okubo","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0585","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1099\/vir.0.023242-0","article-title":"Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations","volume":"92","author":"Cristillo","year":"2011","journal-title":"J Gen Virol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2015.09.030_bib0590","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1742-4690-9-S2-P43","article-title":"Characterization in rabbits & nonhuman primates of the neutralizing antibody response elicited by DNA & protein vaccination with SIVmac251 & SIVsmE660","volume":"9","author":"Menon","year":"2012","journal-title":"Retrovirology"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0595","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2015.1063756","article-title":"Novel nanoparticle vaccines for listeriosis","author":"Calderon-Gonzalez","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0600","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jim.2015.05.009","article-title":"Identification and characterisation of T-cell epitopes for incorporation into dendritic cell-delivered Listeria vaccines","volume":"424","author":"Calderon-Gonzalez","year":"2015","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0605","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.vaccine.2015.01.062","article-title":"A gold glyco-nanoparticle carrying a listeriolysin O peptide and formulated with Advax\u2122 delta inulin adjuvant induces robust T-cell protection against listeria infection","volume":"33","author":"Rodriguez-Del Rio","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0610","doi-asserted-by":"crossref","DOI":"10.1111\/tbed.12314","article-title":"Evaluation of humoral response and protective efficacy of an inactivated vaccine against peste des petits ruminants virus in goats","author":"Cosseddu","year":"2015","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0615","first-page":"35","article-title":"Improving the dromedary antibody response: the hunt for the ideal camel adjuvant","volume":"18","author":"Eckersley","year":"2011","journal-title":"J Camel Pract Res"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.07.051","article-title":"Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protection","author":"Honda-Okubo","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0625","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.celrep.2015.05.003","article-title":"Diverse activators of the NLRP3 inflammasome promote IL-1beta secretion by triggering necrosis","volume":"11","author":"Cullen","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0630","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nm.2403","article-title":"DNA released from dying host cells mediates aluminum adjuvant activity","volume":"17","author":"Marichal","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0635","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/jlb.67.6.767","article-title":"Toll receptors: an expanding role in our understanding of human disease","volume":"67","author":"Schuster","year":"2000","journal-title":"J Leukoc Biol"},{"issue":"September","key":"10.1016\/j.vaccine.2015.09.030_bib0640","article-title":"Immunogenicity and safety of Advax\u2122, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study","author":"Gordon","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0645","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1016\/j.vaccine.2012.06.009","article-title":"Randomized clinical trial of immunogenicity and safety of a recombinant H1N1\/2009 pandemic influenza vaccine containing Advax polysaccharide adjuvant","volume":"30","author":"Gordon","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.09.030_bib0650","doi-asserted-by":"crossref","DOI":"10.1186\/1939-4551-6-S1-P158","article-title":"Immunotherapy \u2013 2076. A controlled study of delta inulin-adjuvanted honey bee venom immunotherapy","volume":"6","author":"Heddle","year":"2013","journal-title":"World Allergy Organ J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15013067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15013067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T16:16:10Z","timestamp":1692029770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15013067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":65,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X15013067"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.09.030","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advax\u2122, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}